Abstract: A drying apparatus is based on supercritical fluid. The drying apparatus includes: an upper cover; a base, arranged below the upper cover and the base and the upper cover; a substrate tray, arranged on the base; a first fluid supply tube, arranged on the top wall of the upper cover; a fluid disturbance plate, arranged below the first fluid supply tube; a second fluid supply tube, arranged on a first side wall of the upper cover; and a fluid discharge tube, arranged on a second side wall of the upper cover. The inner space of the closed chamber can be minimized by using the drying apparatus, thereby saving the usage amount of the supercritical fluid, and reducing the usage costs.

Abstract: The present disclosure relates to a computing device, and related products. The product includes a control unit. The control unit includes an instruction caching unit, an instruction processing unit and a storage queue unit. The instruction caching unit is used for storing a calculation instruction associated with an artificial neural network operation; the instruction processing unit is used for analyzing the calculation instruction to obtain a plurality of operation instructions; and the storage queue unit is used for storing an instruction queue, where the instruction queue includes a plurality of operation instructions or calculation instructions to be executed in the order of the queue. By using the computing device and related products, the present disclosure may improve the operation efficiency of the related products when performing neural network model operations.

Abstract: Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Abstract: The present disclosure provides a circuit, method and system for inter-chip communication. The method is implemented in a computation apparatus, where the computation apparatus is included in a combined processing apparatus, and the combined processing apparatus includes a general interconnection interface and other processing apparatus. The computation apparatus interacts with other processing apparatus to jointly complete a computation operation specified by a user. The combined processing apparatus also includes a storage apparatus. The storage apparatus is respectively connected to the computation apparatus and other processing apparatus and is used for storing data of the computation apparatus and other processing apparatus.

Abstract: Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Abstract: An embodiment of the present disclosure provides an operation apparatus which includes a storage unit, a control unit and a compute unit. The technical solution provided in this disclosure can reduce resource consumption of convolution operation, improve the speed of convolution operation and reduce operation time.

Abstract: The present disclosure provides a winograd convolution operation method, a winograd convolution operation apparatus, a device, and a storage medium. The apparatus includes: processors and a memory, where the memory is configured to store a program code, and the processors are configured to call the program code stored in the memory and execute the operation method. Through the operation method, a system, the device and the storage medium of the present disclosure, performance loss of a computer system may be reduced, and operation speed may be improved. Through the present disclosure, processing efficiency may be improved.

Abstract: This disclosure relates to a data processing method, a data processing apparatus, and related products. The products include a control unit. The control unit includes: an instruction caching unit, an instruction processing unit, and a storage queue unit. The instruction caching unit is used for storing a calculation instruction associated with an artificial neural network computation; the instruction processing unit is used for parsing the calculation instruction to obtain a plurality of computation instructions; and the storage queue unit is used for storing an instruction queue, where the instruction queue includes the plurality of computation instructions or calculation instructions to be executed according to a front-back sequence of a queue. Through the above method of this disclosure, computation efficiency of the related products during a neural network model computation may be improved.

Abstract: Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Abstract: The present invention discloses a camera optical lens with seven-piece lenses including, from an object side to an image side in sequence, a first lens having a positive refractive power, a second lens having a negative refractive power, a third lens having a positive refractive power, a fourth lens having a negative refractive power, a fifth lens having a negative refractive power, a sixth lens having a positive refractive power and a seventh lens having a negative refractive power; wherein the camera optical lens satisfies the following conditions: 20.00?R7/d7?40.00, ?20.00?R13/d13??5.00, and 4.00?d1/d2?15.00. The camera optical lens according to the present invention has excellent optical characteristics, such as large aperture, wide-angle, and ultra-thin.

Abstract: The present disclosure relates to the field of optical lenses and provides a camera optical lens. The camera optical lens includes, from an object side to an image side: a first lens; a second lens having a negative refractive power; a third lens having a negative refractive power; a fourth lens; a fifth lens; and a sixth lens. The camera optical lens satisfies following conditions: 5.00?f1/f?10.00; and 5.00?R3/d3?20.00. The camera optical lens can achieve a high imaging performance while obtaining a low TTL.

Abstract: The present disclosure relates to the field of optical lenses and provides a camera optical lens. The camera optical lens includes, from an object side to an image side: a first lens; a second lens having a negative refractive power; a third lens having a negative refractive power; a fourth lens; a fifth lens; and a sixth lens. The camera optical lens satisfies following conditions: 1.10?f1/f?3.00; and ?25.00?R9/d9??10.00. The camera optical lens can achieve a high imaging performance while obtaining a low TTL.

Abstract: The present disclosure relates to the field of optical lenses and provides a camera optical lens. The camera optical lens includes, from an object side to an image side: a first lens; a second lens having a negative refractive power; a third lens having a negative refractive power; a fourth lens; a fifth lens; and a sixth lens. The camera optical lens satisfies following conditions: 3.00?f1/f?10.00; and 5.00?R11/d11?15.00. The camera optical lens can achieve a high imaging performance while obtaining a low TTL.

Abstract: The present disclosure relates to the field of optical lenses and provides a camera optical lens. The camera optical lens includes, from an object side to an image side: a first lens; a second lens having a negative refractive power; a third lens having a negative refractive power; a fourth lens; a fifth lens; and a sixth lens. The camera optical lens satisfies following conditions: 1.00?f1/f?5.00; and 15.00?R1/d1?30.00. The camera optical lens can achieve a high imaging performance while obtaining a low TTL.

Abstract: The present disclosure discloses a camera optical lens. The camera optical lens including, in an order from an object side to an image side, a first lens, a second lens, a third lens, a fourth lens, a fifth lens, and a sixth lens. The first lens is made of glass material, the second lens is made of glass material, the third lens is made of plastic material, the fourth lens is made of plastic material, the fifth lens is made of plastic material, and the sixth lens is made of plastic material. The camera optical lens further satisfies specific conditions.

Abstract: The present disclosure discloses a camera optical lens. The camera optical lens including, in an order from an object side to an image side, a first lens, a second lens having a positive refractive power, a third lens having a positive refractive power, a fourth lens, a fifth lens, and a sixth lens. The first lens is made of plastic material, the second lens is made of plastic material, the third lens is made of glass material, the fourth lens is made of plastic material, the fifth lens is made of glass material, and the sixth lens is made of plastic material. The camera optical lens further satisfies the following conditions: ?3?f1/f??1; v3?60; 1.7?n5?2.2; 0.03?d3/TTL?0.058. The camera optical lens has the advantage of high performance and satisfies the design requirement of low TTL.

Abstract: The present disclosure discloses a camera optical lens. The camera optical lens including, in an order from an object side to an image side, a first lens, a second lens, a third lens, a fourth lens, a fifth lens and a sixth lens. The first lens is made of plastic material, the second lens is made of plastic material, the third lens is made of glass material, the fourth lens is made of plastic material, the fifth lens is made of plastic material and the sixth lens is made of glass material. The camera optical lens further satisfies specific conditions.

Abstract: Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Abstract: Provided are non-naturally occurring cystine knot peptides (CKPs) that bind to VEGF-A. Additionally, provided are methods of using non-naturally occurring CKPs that bind to VEGF-A, including diagnostic and therapeutic compositions and methods. Non-naturally CKPs that bind low density lipoprotein receptor-related protein 6 (LRP6) are also provided.

Abstract: The invention provides PCSK9 inhibitors, compositions comprising the PCSK9 inhibitors, and methods of identifying and using the PCSK9 inhibitors.